Atb Cap Markets Forecasts Organigram’s Q1 Earnings (TSE:OGI)

Organigram Holdings Inc. (TSE:OGIFree Report) – Stock analysts at Atb Cap Markets issued their Q1 2025 earnings estimates for Organigram in a research report issued on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes forecasts that the company will post earnings per share of ($0.03) for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

Other equities research analysts have also recently issued reports about the company. ATB Capital dropped their price objective on Organigram from C$5.25 to C$3.50 in a research note on Tuesday, December 17th. Canaccord Genuity Group reduced their target price on shares of Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a report on Monday, December 9th.

Check Out Our Latest Research Report on OGI

Organigram Stock Performance

Shares of OGI stock opened at C$2.25 on Monday. Organigram has a one year low of C$1.67 and a one year high of C$3.95. The company has a debt-to-equity ratio of 1.13, a quick ratio of 2.62 and a current ratio of 6.95. The firm’s 50 day moving average price is C$2.25 and its 200-day moving average price is C$2.30. The firm has a market cap of C$244.28 million, a P/E ratio of -0.90, a P/E/G ratio of 0.42 and a beta of 1.13.

Insider Transactions at Organigram

In other Organigram news, Senior Officer Paolo De Luca sold 12,014 shares of the firm’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. Corporate insiders own 31.32% of the company’s stock.

About Organigram

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Further Reading

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.